Literature DB >> 23669187

Paraneoplastic scleroderma-like tissue reactions in the setting of an underlying plasma cell dyscrasia: a report of 10 cases.

Cynthia M Magro1, Hans Iwenofu, Gerard J Nuovo.   

Abstract

INTRODUCTION: Systemic plasma cell dyscrasias have diverse manifestations in the skin and include an inflammatory paraneoplastic process. We encountered cases of scleroderma and eosinophilic fasciitis in the setting of an underlying plasma cell dyscrasia.
MATERIALS AND METHODS: Ten cases of scleroderma-like tissue reactions in the setting of an underlying plasma cell dyscrasia were encountered. The biopsies were stained for Transforming growth factor (Transforming growth factor) beta, IgG4, kappa, and lambda.
RESULTS: Patients presented with a sclerodermoid reaction represented by eosinophilic fasciitis (5 cases), morphea (3 cases), and systemic scleroderma (2 cases). The mean age of presentation was 70 years with a striking female predominance (4:1). Acral accentuation was noted in 8 cases. In 6 of the cases, the cutaneous sclerosis antedated (4 cases) by weeks to 2 years or occurred concurrently (2 cases) with the initial diagnosis of the plasma cell. The biopsies showed changes typical of eosinophilic fasciitis and/or scleroderma. In 5 cases, light chain-restricted plasma cells were present on the biopsy. There was staining of the plasma cells for Transforming growth factor beta in 3 out of 5 cases tested.
CONCLUSIONS: In any older patient presenting with a sudden onset of eosinophilic fasciitis or scleroderma especially with acral accentuation, investigations should be conducted in regards to an underlying plasma cell dyscrasia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23669187     DOI: 10.1097/DAD.0b013e31827adbc8

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  3 in total

1.  An Unusual Case of Morphea in the Setting of Aplastic Anemia.

Authors:  Sierra Mastrantonio; Brian R Hinds; Jeremy A Schneider; Rachel Sennett; David G Cotter
Journal:  Cureus       Date:  2020-04-06

2.  Morphea associated with primary biliary cirrhosis and Waldenstrom macroglobulinemia: Response to rituximab.

Authors:  Danya Traboulsi; Elzbieta A Kaminska; Susan G Barr; Charlene Hunter; P Regine Mydlarski
Journal:  JAAD Case Rep       Date:  2018-09-14

Review 3.  [What's new in clinical dermatology?].

Authors:  M Janier
Journal:  Ann Dermatol Venereol       Date:  2013-11       Impact factor: 0.777

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.